Expression of Epiregulin and Amphiregulin and <i>K-ras</i> Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab
Shirin Khambata‐Ford(Daiichi Sankyo (United States)), David J. Mauro(Moffitt Cancer Center)
Cited by 1,130
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k